Biblio
Export 136 results:
[ Author] Title Type Year Filters: First Letter Of Last Name is R [Clear All Filters]
“APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.”, J Alzheimers Dis, vol. 76, no. 1, pp. 97-119, 2020.
, “Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.”, J Alzheimers Dis, vol. 51, no. 1, pp. 1-9, 2016.
, “Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1395-1408, 2016.
, “Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.”, J Alzheimers Dis, vol. 75, no. 1, pp. 187-199, 2020.
, “A Novel Assessment and Profiling of Multidimensional Apathy in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 1, pp. 57-67, 2017.
, “Implementing Delirium Prevention in the Era of COVID-19.”, J Alzheimers Dis, vol. 79, no. 1, pp. 31-36, 2021.
, “Heparin Modulates the Kinetics of Zinc-Induced Aggregation of Amyloid-β Peptides.”, J Alzheimers Dis, vol. 63, no. 2, pp. 539-550, 2018.
, “PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).”, J Alzheimers Dis, vol. 60, no. 2, pp. 439-450, 2017.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.
, “Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 55, no. 1, pp. 199-217, 2017.
, “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
, “Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.”, J Alzheimers Dis, vol. 69, no. 1, pp. 91-109, 2019.
, “Protofibrillar and Fibrillar Amyloid-β Binding Proteins in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1053-1064, 2018.
, “Self- and Informant-Reported Memory Complaints: Frequency and Severity in Cognitively Intact Individuals and those with Mild Cognitive Impairment and Neurodegenerative Dementias.”, J Alzheimers Dis, vol. 65, no. 3, pp. 1011-1027, 2018.
, “Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
, “Digital Technologies to Prevent Social Isolation and Loneliness in Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 90, no. 2, pp. 513-528, 2022.
, “Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1147-1155, 2016.
, “Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?”, J Alzheimers Dis, vol. 65, no. 2, pp. 321-344, 2018.
, “Higher Fasting Plasma Glucose Levels, within the Normal Range, are Associated with Decreased Processing Speed in High Functioning Young Elderly.”, J Alzheimers Dis, vol. 49, no. 3, pp. 589-92, 2016.
, “African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181.”, J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
, “Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.”, J Alzheimers Dis, vol. 77, no. 3, pp. 935-947, 2020.
, “Exercise-Related Physical Activity Relates to Brain Volumes in 10,125 Individuals.”, J Alzheimers Dis, vol. 97, no. 2, pp. 829-839, 2023.
, “Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 719-29, 2016.
, “Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.”, J Alzheimers Dis, vol. 57, no. 4, pp. 975-999, 2017.
, “Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 1069-1078, 2024.
,